Portola Pharmaceuticals
Portola Pharmaceuticals, Inc.
270 E. Grand Avenue
South San Francisco, CA 94080
Phone: (650) 246 7000
Latest news
- FDA Approves Bevyxxa (betrixaban) for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients
23 June 2017 - Portola Pharmaceuticals Announces FDA Accepts NDA for Priority Review for Oral, Factor Xa Inhibitor Anticoagulant Betrixaban
23 December 2016 - Portola Pharmaceuticals Submits NDA to U.S. FDA for Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism in Acute Medically Ill Patients
25 October 2016
Drugs Associated with Portola Pharmaceuticals, Inc.
Portola Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 1 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Andexxa
Generic name: coagulation factor Xa Drug class: anticoagulant reversal agents |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
Discontinued Drugs
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Bevyxxa
Generic name: betrixaban Drug class: factor Xa inhibitors |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||